[Abstract] The early life period represents a time of immunological plasticity whereby the functionally immature immune system is highly susceptible to environmental stimulation. Perennial aeroallergen and respiratory viral infection induced sporadic episodes of lung inflammation during this temporal window represent major risk factors for initiation of allergic asthmatic disease. Murine models are widely used as an investigative tool to examine the pathophysiology of allergic asthma; however, models in current usage typically do not encapsulate the early life period which represents the time of maximal risk for disease inception in humans. To address this issue, this protocol adapted an experimental animal model of disease for sensitization to ovalbumin during the immediate post-weaning period beginning at 21 days of age. By initially sensitizing mice during this early life post-weaning period, researchers can more closely align experimental allergic airway disease models with the human age group most at risk for asthma development.
www.bio-protocol.org/e3181 2. Gently pour the OVA solution when filtering. Rapid pouring will cause the OVA to denature.
3. All mice were autopsied 24 h after the final OVA aerosol challenge in the original research article (Mincham et al., 2018) . However, this protocol could be used to assess allergic airway inflammation at any time point after the final OVA aerosol challenge.
Recipes

Sterile Phosphate buffered saline (to make 5 L)
a. Dissolve 43.9 g NaCl, 1 g KCl, 5.75 g Na2HPO4, 1 g KH2PO4 in 5,000 ml sterile water in a 5,000 ml volumetric flask and add 0.2 ml HCl b. Once dissolved, filter PBS solution into a sterile 5,000 ml Schott bottle using a 500 ml bottle 
